As seasonal allergies return, sufferers may worry that their symptoms may actually be COVID-19, but there are some key differences.
The U.S. will send desperately needed vaccine supplies and experts to India, overwhelmed by one of the worst coronavirus surges the world has seen, National Security Adviser Jake Sullivan told his counterpart in India on Sunday.
The U.S. will also consider sending millions of surplus AstraZeneca vaccines to India, Dr. Anthony Fauci told ABC’s “This Week.” AstraZeneca’s vaccine has not yet won emergency use authorization in the U.S.
The offers come as the U.S. and other developed nations draw complaints for stockpiling vaccine doses while poorer nations struggle to obtain them. Britain has agreed to ship ventilators to India; the European Union is offering oxygen and other supplies.
Sullivan told Ajit Doval the U.S will make available raw materials to help India manufacture Covishield, the Oxford-AstraZeneca vaccine made in India, along with therapeutics, rapid diagnostic test kits, ventilators and personal protective equipment.
“Just as India sent assistance to the United States as our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need,” a statement from National Security Council spokesperson Emily Horne said.
“The United States also is pursuing options to provide oxygen generation and related supplies on an urgent basis,” the statement added. To help speed India’s vaccine manufacturing, Sullivan said the U.S. Development Finance Corp. will back a “substantial expansion” for BioE, which makes the vaccine, to allow it to reach 1 billion doses by the end of 2022.
And a team of experts from the Centers for Disease Control and Prevention and USAID is being deployed to India to assist.
Also in the news:
►Alaska Airlines said it has banned Alaska state Sen. Lora Reinbold from its flights for refusing to follow mask requirements. Reinbold told the Anchorage Daily News that she had not been notified of a ban and that she hoped to be on an Alaska Airlines flight in the near future.
►More than half of Kansas’ 105 counties have turned down their weekly allotment of coronavirus vaccine doses because demand for the shots has declined.
►A Spanish man with COVID-19 symptoms who coughed on work colleagues and told them, “I’m going to give you all the coronavirus” has been charged with intentionally causing injury after allegedly infecting 22 people in Mallorca.
►Japan’s department stores, bars and theaters shuttered Sunday as part of emergency measures to slow a surge in infections. The 17-day restrictions are declared for Tokyo, Kyoto, Hyogo and Osaka, ahead of the “Golden Week” holidays.
►”Mobile Vax” buses set to administer 500 COVID-19 immunizations per day have begun rolling in Boston. The buses, a joint effort of Tufts Health Plan and Harvard Pilgrim Health Care, focus vaccination efforts on Black, Latino and non-English speaking communities in Massachusetts.
📈 Today’s numbers: The U.S. has more than 32 million confirmed coronavirus cases and 572,000 deaths, according to Johns Hopkins University data. The global totals: More than 146.7 million cases and 3.1 million deaths. More than 290 million vaccine doses have been distributed in the U.S. and 228 million have been administered, according to the CDC.
📘 What we’re reading: As COVID-19 vaccines roll out across the state, many in California’s Slab City – fondly called “the last free place” by residents – either don’t want to be vaccinated or remain hesitant to get their shot.
Keep refreshing this page for the latest updates. Want more? Sign up for our Coronavirus Watch newsletter for updates to your inbox and join our Facebook group.
Europe may welcome fully vaccinated Americans in the summer
Europe is getting ready to reopen its doors to Americans this summer — provided they’re fully vaccinated against COVID-19.
After restricting non-essential travel from outside the European Union for more than a year because of the pandemic, the bloc plans to welcome back vaccinated visitors from the U.S., the New York Times reported Sunday.
All three vaccines authorized for use in the U.S. — those made by Pfizer/BioNTech, Moderna and Johnson & Johnson — have been approved by the European Medicines Agency, a key component of the decision to allow visitors in.
“One thing is clear: All 27 member states will accept, unconditionally, all those who are vaccinated with vaccines that are approved by E.M.A.,” Ursula von der Leyen, president of the European Commission, told the newspaper.
She did not provide a timeline for allowing Americans to travel again to the Old Continent, but pointed out the U.S. has made “huge progress” toward the goal of vaccinating most of its adults by mid-June.
More than 5 million have skipped second dose
The latest data from the CDC highlights the importance of getting the single-dose Johnson & Johnson vaccine back in circulation despite the tiny chance it could lead to blood clots in some women.
More than 5 million Americans who were inoculated with the Pfizer or Moderna vaccine, both of which require two shots weeks apart, have failed to get the second one within the recommended interval. That’s almost 8% of the first-dose recipients, and the numbers are growing.
The New York Times reports that the reasons for skipping the second shot include fear of side effects, lack of supply and feeling that one dose provides enough protection.
Although the U.S. ranks among the leading countries in the world with 42% of the population receiving at least one dose, only 28.5% of the country’s 330 million people are fully vaccinated.
NIH chief pitches J&J vaccine for all; not all agree
Dr. Francis Collins, director of the National Institutes of Health, is all-in on the J&J vaccine for everyone, even though it has been linked to rare but dangerous blood clots in 15 women, mostly under 50. Collins, speaking on NBC’s Meet the Press, said that regardless of age or gender, “when you consider the nature of this risk, this is truly a rare event.” The benefits “greatly outweigh the risks, even for younger women,” he said.
Dr. Leana Wen, an author and professor at George Washington University, doesn’t concur, saying the default position for women under 50 should be to find another vaccine.
“I respect @NIHDirector very much. However, I disagree with him strongly,” tweeted Wen, who said she chose to receive the J&J vaccine. As woman under 50, Wen says she wouldn’t make the same decision now. She said that while the risk is low, the Moderna and Pfizer vaccines don’t carry the risk.
“If I knew then what I know now about the risk of a rare but serious blood clotting disorder, I would have chosen another vaccine,” she said.
MIT professors challenge safety of 6-foot rule
Six feet of distance or 60 feet of distance – it makes little difference indoors for avoiding exposure to COVID because tiny droplets tend to distribute throughout closed spaces, an MIT study says. Authors Martin Bazant, a professor of chemical engineering at the school, and John Bush, director of MIT’s Applied Math Laboratory, factor in the extent to which transmission risk is reduced in large rooms with high air exchange rates, increased for more vigorous respiratory activities and dramatically reduced by the use of face masks.
“The current revival of the American economy is being predicated on social distancing, specifically the six-foot rule, a guideline that offers little protection,” the study says.
States begin administering J&J vaccine
California and New York were among states administering the Johnson & Johnson COVID vaccine Sunday after their governors signed off on resuming use of the one-dose shot. The J&J product could expedite mass vaccinations as Americans grow weary of wearing masks and a new study indicates social distancing indoors may not be helping much.
“After additional review of the J&J #COVID19 vaccine, CA will resume administering it immediately,” California Gov. Gavin Newsom tweeted late Saturday. “Grateful to count myself one of the 1 million Californians to receive this safe, effective vaccine.”
Arizona, Colorado, Connecticut, Indiana, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nevada, Tennessee, Texas and Virginia also have given the green light to the J&J vaccine. Federal health officials recommended pausing use of the vaccine almost two weeks ago after a rare blood clotting disorder was associated with the shot. The government has uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J shot. Three died, and seven remain hospitalized.
Federal health officials dropped the recommendation Friday, saying the vaccine is critical to fight the pandemic and that the small clot risk could be handled with warnings.
82 die in blast at Baghdad hospital COVID ward
The death toll rose to 82 Sunday after an explosion and fire in the intensive care unit of a Baghdad hospital tending to severely ill Iraqi coronavirus patients.
Iraq’s Interior Ministry said 110 others were injured. Negligence on the part of hospital authorities has been blamed for the Saturday night blaze that initial reports suggest was caused when an oxygen cylinder exploded in the ward of Ibn al-Khatib hospital. Prime Minister Mustafa Al-Kadhimi fired key hospital officials hours after the catastrophic incident and demanded that the Interior Ministry complete an investigation within 24 hours.
Relatives were still searching anxiously on Sunday for missing loved ones.
“Please, two of my relatives are missing. … I am going to die (without news about them),” posted a young woman on social media. “I hope someone can help us find Sadi Abdul Kareem and Samir Abdul Kareem, they were in the ICU.”
Last SlideNext Slide
Contributing: Katie Wadington, USA TODAY; The Associated Press
Read or Share this story: https://www.usatoday.com/story/news/health/2021/04/25/covid-news-california-washington-among-states-using-j-j-jabs-again/7371553002/